Natco applied CL for Pfizer drug Maraviroc


Natco applied for Compulsory Licenses for Pfizer’s HIV drug Maraviroc

Maraviroc seems to be protected by 204132 (885/MUM/1999) and other pending applications 867/BOM/1999 and 1939/MUM/2006. ‘132 patent is granted on Jun 08, 2007 published in Gazette no 23/2007.

Natco has applied for CL in November 2010 (as per ET report).

ET report

…. Pfizer has time till May to reply, as Indian patent law allows an innovator company to respond within six months of receiving a notice for voluntary license. If it does not allow Natco to make cheap drugs, the Indian pharma company can approach the government for CL, that will allow it to sell a lowpriced version of the drug after paying royalty to Pfizer….

[Original link]

Updates

204132 (885/MUM/1999) is again published on 31st Dec 2010 as 204132 (885/BOM/1999)

Advertisements

About Guna

Interested to learn things around me
This entry was posted in Patent case. Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s